LAS VEGAS, NV--(Marketwired - Feb 16, 2016) - BioAdaptives, Inc. (OTCBB: BDPT) announced the completion of a transaction to purchase inventory valued at just under $1,100,000 in retail products. The products include PrimiCell®, PrimiLive®, PrimiTrim™, and Equine Regen® Plus.
In addition, BioAdaptives is securing additional manufacturing capacity to the cover the expected demand for the next two years.
Christopher G. Hall, President of BioAdaptives, said, “By bringing inventory in-house this all stock transaction puts BioAdaptives in a much stronger position to handle rapid order fulfillment as we expand our distribution channels.”
About BioAdaptives, Inc.
BioAdaptives, Inc. is a fully reporting, public company trading on the OTC Bulletin Board under the symbol BDPT. The company is engaged in research and development in science-based nutraceutical products for human and animal consumption. The company’s focus is to source high quality, unique, raw material worldwide and develop science-based products to improve health and wellness in both humans and animals. BioAdaptives, Inc. owns the rights to a proprietary non-invasive bioelectromagnetic and sonic device for improving individual ingredients, food, beverages, and wellness.
